Comp SA (CMP.WA) stock: key figures, P/E, revenue and dividend
Information Technology · Poland · ISIN PLCMP0000017
Comp SA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 903.00 m PLN | 846.51 m PLN |
| Gross profit | 286.00 m PLN | 278.19 m PLN |
| Operating income | – | 89.21 m PLN |
| EBIT | 75.00 m PLN | – |
| Net income | 38.00 m PLN | 76.45 m PLN |
| Diluted EPS – continuing operations | 1.74 PLN | – |
Full history since 2001, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Comp SA
Comp S.A., a technology firm, provides IT security and network security services and solutions in Poland. The company operates through Retail and IT segment. The company offers special security and system solutions, which includes special security and cryptography, software development, IT integration services, e-signature, and e-services; and infrastructure and IT services, such as Logistic, remote IT support, outsourcing of local IT resources, and IT equipment services. It also provides networks and network security solutions, comprising designing and construction of telecommunications and computer networks; protection of system and network resources, virtualization, automation, and migration of systems; and M/platform, a digital service platform that offers a real support to retail stores in the SME sector. Tin addition, the company supplies fiscal and non-fiscal devices to the Greek market; engages in production and sale of calculating, masking, and electronic scales; and devices for cutting meats. The company was founded in 1990 and is headquartered in Warsaw, Poland.
More stocks
- Hefei Taihe Optoelectronic (603656.SS)
- Beijing Trust Far Tech (300231.SZ)
- Binggrae (005180.KS)
- innoscripta (1INN.MU)
- Ningbo Solartron Technology Co Ltd (688299.SS)
- YungShin Global Holding Corp (3705.TW)
- Hubei Xiangyuan New Material Technology Inc. (300980.SZ)
- Zhejiang Yatai Pharmaceutical Co Ltd (002370.SZ)
- Atria Oyj (ATRAV.HE)
- Heren Health Co Ltd (300550.SZ)
- CRESCENT BIOPHARMA, INC. (CBIO)
- Zhejiang Zhengte Co Ltd (001238.SZ)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.